These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7537605)

  • 21. A clinical phase II study of ProMACE-CytaBOM.
    Dahlberg S; Miller TP; Fisher RI
    J Clin Oncol; 1991 May; 9(5):888. PubMed ID: 1707958
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnosis and treatment of germ cell tumors of the ovary].
    Sawada M; Matsui Y; Okudaira Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2489-95. PubMed ID: 6210050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.
    Ledermann JA; Holden L; Newlands ES; Begent RH; Rustin GJ; Bagshawe KD; Brampton M
    Br J Urol; 1994 Aug; 74(2):225-30. PubMed ID: 7522874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The UK Children's Cancer Study Group: testicular malignant germ cell tumours 1979-1988.
    Huddart SN; Mann JR; Gornall P; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendsus KR
    J Pediatr Surg; 1990 Apr; 25(4):406-10. PubMed ID: 1691781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour markers and POMB/ACE chemotherapy in the management of ovarian germ cell tumours (GCTs).
    Newlands ES; Holden L; Bagshawe KD
    Int J Biol Markers; 1988; 3(3):185-92. PubMed ID: 2466094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis following chemotherapy for metastatic malignant teratoma.
    Horwich A; Easton D; Husband J; Nicholas D; Peckham MJ
    Br J Urol; 1987 Jun; 59(6):578-83. PubMed ID: 2446691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Principle products used in chemotherapy. Administration methods].
    Boillon C; Olivro A; Lemerle J
    Soins; 1979 Aug 5-20; 24(15-16):51-9. PubMed ID: 90390
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-hodgkins lymphoma.
    Mead G; Woodcock J; Young C
    Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combination chemotherapy with bleomycin, vincristine and methotrexate for stage I non-seminomatous germ cell testicular tumors].
    Fukui I; Yokokawa M; Wakui M; Washizuka M; Katoh M; Igarashi K; Takeuchi S; Gotoh S; Afuso H; Tachibana Y
    Hinyokika Kiyo; 1983 Feb; 29(2):191-8. PubMed ID: 6203379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
    Bron D; Vandenheule B; Stryckmans P
    Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298
    [No Abstract]   [Full Text] [Related]  

  • 31. Failure of normalisation of alpha fetoprotein concentration after successful treatment of teratoma.
    Pandha HS; Wasan HS; Harrington K; Waxman J
    BMJ; 1995 Aug; 311(7002):434-5. PubMed ID: 7543786
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary treatment with vincristine, dactinomycin, and cyclophosphamide in nondysgerminomatous germ cell tumor of the ovary.
    Wong LC; Ngan HY; Ma HK
    Gynecol Oncol; 1989 Aug; 34(2):155-8. PubMed ID: 2753421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
    Skinner DG; Scardino PT
    Trans Am Assoc Genitourin Surg; 1979; 71():31-5. PubMed ID: 94715
    [No Abstract]   [Full Text] [Related]  

  • 34. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
    Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
    Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful treatment of a primary endodermal sinus tumor of the liver.
    Whelan JS; Stebbings W; Owen RA; Calne R; Clark PI
    Cancer; 1992 Nov; 70(9):2260-2. PubMed ID: 1382827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful management of metastatic and primary germ cell tumors in the brain.
    Rustin GJ; Newlands ES; Bagshawe KD; Begent RH; Crawford SM
    Cancer; 1986 Jun; 57(11):2108-13. PubMed ID: 2421864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germ cell tumours.
    Stanhope CR; Smith JP
    Clin Obstet Gynaecol; 1983 Aug; 10(2):357-64. PubMed ID: 6193922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.
    Hitchins RN; Newlands ES; Smith DB; Begent RH; Rustin GJ; Bagshawe KD
    Br J Cancer; 1989 Feb; 59(2):236-42. PubMed ID: 2467682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-risk metastatic gestational trophoblastic tumors. Current management.
    Lurain JR
    J Reprod Med; 1994 Mar; 39(3):217-22. PubMed ID: 7518518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.